For example, in bladder cancer, NR2F1-AS1 has been identified as a glycolysis-related lncRNA capable of stratifying patients into high- and low-risk groups, with robust predictive performance as validated by ROC curve analysis [32–34]. Here, NR2F1 is linked to urinary bladder carcinoma.